Miló-Valdés CA, Orraca-Castillo O, Valdés-Acosta M, Barreras-Sixto D, Valdés-Soho C, Hernández-González JL

Language: Spanish
References: 15
Page: 1-8
PDF size: 377.55 Kb.

ABSTRACT

Introduction: increased susceptibility to infectious processes is considered the main sign suggestive of immunodeficiency; however, other manifestations such as those of hematological and/or oncological nature may be part of the evolution and even the onset of an inborn error of immunity.
Objective: to identify patients with probable diagnosis of inborn errors of immunity in the pediatric oncohematology service at Pepe Portilla Pediatric Provincial Teaching Hospital in Pinar del Rio during the period from January 1979 to March 2021.
Methods: an observational, descriptive, cross-sectional study was carried out with a sample of 103 patients. The following variables were studied: diagnosed oncohematological disease, probable diagnosis of inborn error of immunity and alarm signs of primary immunodeficiency.
Results: the diagnosis of some oncological disease reached 87,4 %. Five patients were found with a probable diagnosis of an inborn error of immunity (Fanconi's anemia and Medullary Aplasia); 54,5 % of non-leukemic patients and only 24,1 % of leukemic patients had at least one and up to three alarm signs for immunodeficiency.
Conclusions: the Jeffrey Modell Foundation alarm signs for the diagnosis of primary immunodeficiencies were not useful in patients with hematopathies; therefore other criteria for the identification of these disorders could be implemented. These patients should be re-evaluated by the provincial immunology group with a view to the diagnosis of inborn errors of immunity and their comprehensive treatment.

REFERENCES

1. Notarangelo LD, Bacchetta R, Casanova JL, Su HC, Branch R, Hospital N, et al. Human Inborn Errors of Immunity: an Expanding Universe. Sci Immunol [Internet]. 2020 [citado 26/1/2022]; 5(49). Disponible en: Disponible en: https://doi.org/10.1126/sciimmunol.abb1662 1. .

2. Solé D. Primary immunodeficiencies?: a diagnostic challenge?? J Pediatr (Rio J) [Internet]. 2021 [citado 26/1/2022]; 97(1): S1-2. Disponible en: Disponible en: https://doi.org/10.1016/j.jped.2020.12.002 2.

3. Tangye SG, Al-herz W, Bousfiha A, Chatila T, Cunningham-rundles C. Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol [Internet]. 2020 [citado 26/1/2022]; 40(1): 24-64. Disponible en: Disponible en: https://doi.org/10.1007/s10875-019-00737-x 3.

4. Grumach AS, Goudouris ES. Inborn Errors of Immunity?: how to diagnose them?? J Pediatr (Rio J) [Internet]. 2021 [citado 26/1/2022]; 97(Suppl 1): S84--S90. Disponible en: Disponible en: https://doi.org/10.1016/j.jped.2020.11.007 4.

5. Rodrigues G, Segundo S. Genetic-molecular characterization in the diagnosis of primary immunodeficiencies. J Pediatr (Rio J) [Internet]. 2021 [citado 26/1/2022]; 97 (Suppl 1): S3--S9. Disponible en: Disponible en: https://doi.org/10.1016/j.jped.2020.09.007 5.

6. Verhoeven D, Jan A, Meyer-wentrup F, Boes M. Increased risk of hematologic malignancies in primary immunode fi ciency disorders?: opportunities for immunotherapy. Clin Immunol [Internet]. 2018 [citado 26/1/2022]; 190: 22-31. Disponible en: Disponible en: http://dx.doi.org/10.1016/j.clim.2018.02.007 6.

7. Maffeis M, Notarangelo LD, Schumacher RF, Soncini E, Soresina A, Lanfranchi A, et al. Primary Immunodeficiencies and Oncological Risk?: The Experience of the Children ' s Hospital of Brescia. Frot Pediatr [Internet]. 2019 [citado 26/1/2022]; 7: 232. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593615/ 7.

8. Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. J Clin Immunol [Internet]. 2020 [citado 26/1/2022]; 40(1): 66-81. Disponible en: Disponible en: https://doi.org/10.1007/s10875-020-00758-x 8.

9. Jeffrey Modell Foundation. 10 Warning Signs of Primary Immunodeficiency [Internet]. 2021 [citado 26/1/2022]. Disponible en: Disponible en: http://downloads.info4pi.org/pdfs/JMF_10Signs_Generic_082421_v2.pdf 9.

10. Abolhassani H, Havoshzadeh Z, Mahdaviani SA, Momen T, Sherkat R, Sadeghi-shabestari M, et al. Global systematic review of primary immunodeficiency registries. Expert RevClin Immunol[Internet]. 2020 [citado 26/1/2022]; 16(7): 717-732. Disponible en: Disponible en: https://doi.org/10.1080/1744666X.2020.1801422 10.

11. Abd I, Azman NA, Gennery AR, Mangantig E, Hashim IF, Zainudeen ZT. Systematic Review of Primary Immunodeficiency Diseases in Malaysia?: 1979 - 2020. Front Immunol [Internet]. 2020 [citado 26/1/2022]; 11(1923). Disponible en: Disponible en: https://www.frontiersin.org/articles/10.3389/fimmu.2020.01923/full 11.

12. Casado Hernández I. Inmunodeficiencias primarias y citopenias. Rev Cuba Hematol Inmunol y Hemoter [Internet]. 2019 [citado 26/1/2022]; 35(4): 1-17. Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892019000400002 12.

13. Tavares Costa-carvalho B, Sevciovic Grumach A, Franco JL, Espinosa-rosales FJ, Leiva LE, King A, et al. Attending to Warning Signs of Primary Immunodeficiency Diseases Across the Range of Clinical Practice. J Clin Immunol[Internet]. 2014 [citado 26/1/2022]; 34: 10-22. Disponible en: Disponible en: https://doi.org/10.1007/s10875-013-9954-6 13.

14. John Hopkins Medicine. Failure to Thrive [Internet]. John Hopkins Medicine; 2022 [citado 2/2/2022]. Disponible en: Disponible en: https://www.hopkinsmedicine.org/health/conditions-and-diseases/failure-to-thrive 14.

15. MedlinePlus. Failure to Thrive [Internet]. MedlinePlus; 2022 [citado 2/2/2022]. Disponible en: Disponible en: https://medlineplus.gov/ency/article/000991.htm 15.